GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

YD Bio YDES · USD

N/A · US listing · 🇺🇸 United States

Compare

6.71

+12.40%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About YD Bio

Its shares trade under the ticker YDES. It has been listed since 29 August 2025. In the fiscal year to 31 December 2025, it reported revenue of $596,817 and a net loss of $8.3m. At that date it held total assets of $13.8m and shareholders' equity of −$2.9m.

YD Bio Ltd is a TW-based company operating in industry. The company is headquartered in Taipei City, Taipei. The company went IPO on 2025-08-29. YD Bio Ltd is a Taiwan-based company principally engaged in pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. The Company’s core areas include non-invasive cancer detection tools for early diagnosis and monitoring, ophthalmologic products targeting dry eye conditions, and exosome-based therapeutics aimed at treating complex diseases. By integrating cutting-edge science with accessible solutions, YD Bio strives to improve patient outcomes and quality of life.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
29 Aug 2025
Head office
12F., NO. 3, XINGNAN ST., TAIPEI CITY, 115001
Incorporated in
E9
Classification
Services-Medical Laboratories
Filer status
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Leadership

Pay as last reported

  • Dr. Ethan ShenChairman of the Board, Chief Executive Officer, since 2024
  • Mr. Edmund HenChief Financial Officer
  • Dr. J. Douglas RamseyDirector, since 2020
  • Ms. Jan HallDirector
  • Mr. Benjamin ZhangChief Medical Officer & Director
  • Mrs. Michaela GriggsIndependent Director
  • Mr. Albert MclellandIndependent Director
  • Mr. Chia Lee YinIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • YD Bio Ltd is headquartered in Taipei City, Taiwan.
  • The company focuses on early cancer detection and cell therapies.
  • YD Bio Ltd has a planned IPO date of 2025-08-29.

Weaknesses

  • The company operates in an unclassified sector and industry.
  • The company's website is provided as http://ir.ydesgroup.com/.
  • The company's source description is marked as untrusted.

Opportunities

  • The company aims to pioneer transformative solutions in healthcare.
  • YD Bio Ltd targets non-invasive cancer detection tools for early diagnosis.
  • The company is developing exosome-based therapeutics for complex diseases.

Threats

  • The company's sector and industry are listed as N/A.
  • The company's source description is untrusted and may contain inaccuracies.
  • The company has not yet completed its IPO as of the provided information.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.